Evidence map›Paper›PMID 38938260›Full record

ArticleJACC. Advances2023

Care Fragmentation Following Hospitalization for Atrial Fibrillation in the United States.

Arjun Verma, Josef Madrigal, Troy Coaston, Nameer Ascandar, Catherine Williamson, Peyman Benharash

Abstract read
In one paragraph

Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arjun VermaCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Josef MadrigalCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Troy CoastonCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Nameer AscandarCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Catherine WilliamsonCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Peyman BenharashCardiovascular Outcomes Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the high prevalence of atrial fibrillation (AF), the incidence and impact of care fragmentation (CF) following hospitalization for this condition remain unstudied. Objectives: The present study used a national database to determine the incidence of and risk factors associated with CF. Outcomes following CF were also examined. Methods: All adults who were discharged alive following hospitalization for AF (index facility) were identified within the 2016 to 2019 Nationwide Readmissions Database. Patients requiring nonelective rehospitalization within 30 days of discharge were categorized into 2 groups. The CF cohort included those readmitted to a nonindex facility, while others were classified as noncare fragmentation. Multivariable regression was used to evaluate factors associated with CF, as well as its impact on in-hospital mortality, length of stay, and costs at rehospitalization. Results: Of an estimated 686,942 patients who met study criteria and survived to discharge, 13.6% (n = 93,376) experienced unplanned readmission within 30 days. Among those readmitted, 21.3% (n = 19,906) were readmitted to a nonindex facility. Patients who experienced CF were younger, more commonly male and less frequently readmitted for AF. Upon multivariable adjustment, male sex, Medicaid insurance (ref: private), and transfer status were associated with increased odds of CF. Upon readmission, CF was associated with a 18% increment in relative odds of in-hospital mortality, a 0.3-day increment in length of stay, and an additional $1,500 in hospitalization costs. Conclusions: CF was associated with significant clinical and financial burden. Further studies are needed to address factors which contribute to increased mortality and resource use following CF.

Indexed as

atrial fibrillationcare fragmentationNationwide Readmissions Databasenonelective readmissionsresource use

Identifiers

PMID38938260
PMCPMC11198211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.